Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

Structural tailwinds from hospital reform driving growth in German outpatient intensive care sector- Dr Erik Hamann, Opseo 

Germany’s outpatient intensive care market is entering a period of structural change, creating significant opportunities for providers with scale, according to Dr Erik Hamann, CEO of Opseo, a German provider of intensive care services. HBI recently spoke to Hamann about Germany’s hospital reform, increasing regulatory complexity and ongoing market consolidation. These trends are reshaping the […]

HBI webinar on Value Creation in Healthcare Organisations

HBI hosted a webinar this week on the topic of value creation in healthcare organisations. The discussion looked at how healthcare providers are using digital tools, operational improvements and AI to build more connected and scalable organisations. Missed the webinar? Watch the recoding here.

Interview with Niklas Kouparanis, founder and CEO of Europe’s largest medical cannabis digital health company, Bloomwell

Germany’s medical cannabis market has been booming since it was removed from the list of controlled narcotic substances in 2024, which made prescribing it much easier. Now as many as one million Germans are being prescribed cannabis, according to the most often cited figure by those in the industry. The majority of these prescriptions are being handed out by digital health companies specialising in cannabis. The largest of these companies is Bloomwell, who HBI sat down with last week at Cannabis Europa (a conference focused on medicinal cannabis).

Private equity has record dry powder, but mid-market healthcare assets remain tightly held —  John DiGiovanni, Inflexion

HBI spoke with John DiGiovanni, recently appointed Head of Healthcare at European mid-market private equity firm Inflexion. DiGiovanni discusses Inflexion’s healthcare strategy for 2026, trends in pharma services and medtech, and the broader market forces shaping its investment approach.

Building an optimised platform in a fragmented UK aesthetics market— Interview with Skingevity Founders, Enrico Ghio & Andrea Agnolio

HBI spoke with Skingevity co‑founders Andrea Agnolio (former Principal at The Boston Consulting Group) and Enrico Ghio (former Executive Director at Goldman Sachs) about their strategy, why now is the right time to consolidate the UK aesthetics market, and the key trends shaping the sector. 

We focus on mission-critical, highly verticalised software for specific operational and clinical needs — Charles Bourgain, Executive Director, Extens

HBI spoke with Charles Bourgain, Executive Director at Extens, about the firm’s sector-focused investment strategy and the growing role of AI in healthcare IT.

Delivering value through an integrated healthcare service platform — Interview with David Rolfe, Group CEO, Ergéa

HBI spoke with David Rolfe, the recently appointed Group CEO of Ergéa, a pan-European provider of Managed Equipment Services (MES) and clinical outsourcing. The company works with both public and private healthcare systems across diagnostics and oncology. In this interview, we discuss Ergéa’s growth plans, opportunities in the European healthcare market, and the key trends shaping the sector.

How European real estate investors and care operators can build profitably and sustainably — interview with Alberto Fernandez, Healthcare Activos

Healthcare Activos is a Spanish specialist healthcare REIT investing in nursing homes, hospitals, mental health clinics and rehab centres across Europe. Currently it has 84 assets under management, worth over €1.3 billion. Healthcare Activos has two distinguishing features which set it apart from the other major healthcare real estate investors in Europe. One is that they prefer to buy individual properties rather than portfolios, as they prefer to pick and choose the best assets based on their fundamentals (catchment area, design, effort rate, operator, lease agreement) on a case-by-case basis. Secondly, and relatedly, they have a strong focus on new builds, which they design themselves.

Simplified IT and sales processes key to accelerating AI adoption in imaging — DeepHeath’s Niccolo Stefani

US-based outpatient diagnostic imaging services provider RadNet has recently acquired French radiology AI company Gleamer in an all-cash transaction valued at €230 million (~$270 million). HBI spoke to Niccolo Stefani, Business Leader Population Health & Clinical AI, RadNet DeepHealth, about what this acquisition means for the AI platform and the overall adoption of AI in imaging.

Navigating the global pharma order in 2026 —in conversation with ING’s Stephen Farrelly and Diederik Stadig

Ahead of the HBI 2026 session ‘The new global pharma order: Trump, China and Europe's uncertain future’, HBI spoke to Stephen Farrelly, Managing Director, Global Lead Healthcare & Pharma at ING and Diederik Stadig, Senior Economist, Healthcare & Pharma at ING on what the future holds for pharma investment and strategy, from regulatory risks and European biopharma's structural challenges to the evolving role of CDMOs, CROs, and the role of private equity.

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us